Cargando…
Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma
Riproximin (Rpx) is a type II ribosome-inactivating protein with specific anti-proliferative activity. It was purified from Ximenia americana by affinity chromatography using a resin coupled with lactosyl residues. The same technique facilitated isolation of proteins with lectin-like properties from...
Autores principales: | Sagini, Micah N., Klika, Karel D., Orry, Andrew, Zepp, Michael, Mutiso, Joshua, Berger, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734336/ https://www.ncbi.nlm.nih.gov/pubmed/33328982 http://dx.doi.org/10.3389/fphar.2020.549804 |
Ejemplares similares
-
The ribosome inhibiting protein riproximin shows antineoplastic activity in experimental pancreatic cancer liver metastasis
por: Murtaja, Ahmed, et al.
Publicado: (2018) -
The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment
por: Sagini, Micah N., et al.
Publicado: (2018) -
Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021) -
Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
por: Schnipper, Julie, et al.
Publicado: (2020)